AI has rapidly progressed from being merely a computational helper to a functional co-researcher in clinical trials. Nowadays, algorithmic methods are entailed in protocol development, patient selection, adaptive drug dosing, and real-time safety evaluation. However, Indian law still anticipates a research environment run solely by human researchers. The discrepancy between technology’s potential and its legal acknowledgement has resulted in a multifaceted regulatory scenario that needs healthcare regulatory compliance lawyers and healthcare data privacy law firms.

Existing Regulatory Framework
The Drugs and Cosmetics Act, 1940 (DCA) and Drugs and Cosmetics Rules, 1945 (DCR) primarily control clinical trials in India. The older Schedule Y (superseded now) defined standards for trial performance, informed consent, and safety reporting, among other parameters. The New Drugs and Clinical Trials Rules, 2019 – which superseded the older Schedule Y – brought significant changes in India’s clinical trials landscape. It not only defined procedures for approval but also made ethics committee registration a prerequisite. Besides, the legislation established new criteria for safety and compensation. Further, the ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants of 2017 and the GCP Guidelines of CDSCO provide a structure for ethically responsible conduct of clinical trials. Besides, legal advisory for hospitals and wellness centres mandates that the healthcare sector must remain fully compliant with both legislative and regulatory requirements.

AI as Co-Researchers: Evolving Scenario
AI-assisted clinical trials raise several unprecedented legal and ethical questions:
● Defining “Investigator”: According to NDCTR, an investigator is defined as a person who is responsible for carrying out the trial. The situation, however, is different if the AI model performs safety signal detection or recommends protocol amendments—is it just a tool or an entity affecting the trial design?
● Informed Consent: The Apex Court, in the landmark case of Swasthya Adhikar Manch v. Union of India (2013), observed that informed consent and patient protection were not adequately enforced and thus, the new regulations came into being. In the AI-assisted trials, the subjects might need a more sophisticated version of “intelligible consent”, which would provide an extensive discussion of the algorithmic decision-making process’s role, limitations, and risks—a field where the current consent forms do not suffice.
● Liability and Accountability: If AI recommendations go awry, the legislation is unclear on who will be considered guilty – whether the sponsor, investigator, developer, or the institution. The NDCTR 2019 (Schedule VII) mandates providing compensation; the Responsibility of AI-based decisions is still unclear.
● Data protection and Privacy: AI systems depend on sensitive human and health data. The data-protection is rapidly evolving (including the DPDP Rules 2025, EHR Standards 2016, Information and Technology Act, 2000, etc.) and has implications for data usage, algorithmic profiling, and automated decision-making in clinical research.

Legislative Evolution: Potential Direction
In the future, the regulatory framework of India will have to clearly state the participation of AI in clinical trials. The first step would be to grant AI a place under the NDCTR through specific guidelines, thereby creating a formal definition of AI as either a decision-support system or a technology having a considerable impact on clinical results. Ethics Committees might also want detailed AI-risk assessments to be done that would cover issues like model validation, bias, reliability, and the measure of human oversight. It would be necessary to update the informed-consent templates so they will require precise disclosures about the involvement of algorithms—how AI tools are incorporated in the processes of screening, monitoring, or decision-making—and what risks are taken due to the automated processes. The regulations could also impose obligations for keeping audit trails of algorithms, version histories, and validation reports. All these changes together would make it certain that AI-assisted clinical trials in India would be safe, ethical, and in line with the changing biomedical governance landscape. Consequently, the need for the Pharmaceutical regulatory legal services and Medical malpractice defence law firm is also rising among the ecosystem players.

AI is not a peripheral tool anymore; it is an energetic participant in clinical research. The legal framework of India, although strong enough for conventional trials, should change in such a way that the trials with the use of AI would still be ethical, transparent, and focused on the participants. Changing the laws and guidelines at this point will not only help in reducing the risk but also build confidence in India’s fast-growing biomedical research landscape.

Adv. Varun Singh
Founder & Managing Partner
Foresight Law Offices India

The post Evolving Legal Frameworks for AI-Assisted Clinical Trials appeared first on Health Vision.

In ancient times, humans lived closer to nature—walking barefoot, sleeping on the ground, and working under the sun. Our bodies naturally absorbed Earth’s electromagnetic field (EMF), keeping us balanced and healthy. But today, due to concrete structures, rubber soles, and constant digital exposure, we’ve become disconnected from this vital energy source.

Maniraya Magnetic Therapy is a scientifically formulated solution that bridges this gap. With strategically placed magnets and infra-red technology, our therapy mats restore your body’s natural alignment, reduce inflammation, and re-energize your internal systems.

How It Works
• Magnetic fields stimulate microcirculation, ensuring better blood flow.
• North-pole bio-magnets interact with iron in the blood, oxygenating tissues more effectively.
• The mat’s fabric emits far-infrared rays (FIR) that penetrate deep into muscles, relaxing them and reducing fatigue.
• It balances ions and pH levels, making the body an environment where diseases struggle to thrive.

❤️ Protecting the Heart & Preventing Strokes Naturally

Why Focus on the Heart?
Heart attacks and strokes are no longer limited to the elderly. Even individuals in their 30s are falling victim to cardiac issues due to:
• Sedentary lifestyle
• Processed food
• Sleep disorders
• High stress
• Poor blood circulation

Maniraya Magnetic Therapy is clinically supported to:
• Increase blood oxygenation
• Dilate blood vessels naturally
• Reduce the formation of blood clots
• Improve the elasticity of heart muscles
• Stabilize irregular heart rhythms

Case Study Highlight
One of our clients, a 52-year-old diabetic and hypertensive patient, began using the Maniraya mat daily for 60 minutes. Within 90 days:
• His BP normalized from 160/110 to 125/80
• Sleep improved drastically
• Cholesterol dropped 20 points
• His doctor reduced medication dosage
Thousands of similar stories highlight the undeniable power of this therapy.

🌐 Earth Energy Passer – What You’re Missing Every Day

What is Earth Energy & Why Does it Matter?
The Earth constantly emits low-frequency electromagnetic waves that:
• Ground our nervous system
• Balance our body’s electric field
• Detoxify cells through enhanced lymphatic flow
Most people suffer from ‘magnetic starvation’—a real phenomenon where the lack of grounding causes anxiety, hormonal imbalance, body pain, and fatigue.

Maniraya Magnetic Mats act as an Earth Energy Passer, delivering this energy safely into the body. Regular use results in:
• Restored energy levels
• Reduced cortisol (stress hormone)
• Deeper sleep cycles
• Strengthened immune system
• Balanced endocrine (hormonal) functions

Who Should Use It?
✅ Students with focus issues
✅ Office goers with long screen time
✅ Women with hormonal imbalances
✅ Athletes for faster recovery
✅ Senior citizens for better circulation
✅ Heart and stroke patients
✅ Diabetes and BP sufferers

🚨Mandatory for Every Home – The Maniraya Vision

Why You Shouldn’t Wait for Symptoms
Most health problems today are silent and progressive. Waiting for symptoms to appear could be too late. Prevention is always better—and more affordable—than treatment.

Unique Features of Maniraya Magnetic Therapy:
• No electricity required
• Lightweight, foldable, easy to carry
• One-time investment, lifetime benefits
• Used while sleeping or resting
• Suitable for all ages
• No side effects
• Scientifically designed by wellness experts

More Than a Product – It’s a Mission
Maniraya is not just a brand; it’s a health movement. With over 15,000 users, ₹4+ crore payouts, and zero product returns, we are setting benchmarks in quality, satisfaction, and results.

We also offer career opportunities for those who wish to spread health and wealth across India by becoming Maniraya leaders.

🔹 Customer Testimonials:

🗣 “I used to wake up with back pain and BP issues. Within two weeks of using the magnetic mat, I felt younger and slept like a child!” – Nagesh R, Mysuru

🗣 “My father avoided bypass surgery thanks to the change in circulation from Maniraya’s therapy. It’s truly a miracle.” – Kavitha P, Kerala

📞 Act Now. Live Better.
Contact us today to get your own Maniraya Magnetic Therapy Mat or to become a certified distributor in your region.
📧 Email: growmaniraya@gmail.com
📱 WhatsApp: 88844 48586
🌐 Web: www.maniraya.in

Nithin Manjappa
Managing Director

Harshitha G
Director

MANIRAYA Marketing Pvt Ltd
33 1st Floor, 9th A Cross, HIG A Sector
Yelahanka New Town, Bengaluru – 560064

The post Science Behind Maniraya Magnetic Therapy appeared first on Health Vision.

Medical imaging has evolved dramatically over the past few decades, with hybrid imaging technologies leading the charge. Among these, PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) stands out as a ground-breaking fusion of two powerful modalities. Combining the molecular sensitivity of PET with the superior soft-tissue contrast of MRI, this hybrid system is increasingly recognized as the gold standard for precision diagnostics in oncology, neurology, and cardiology.

But why is PET/MRI gaining such prominence? How does it outperform standalone PET/CT or MRI? And what does this mean for the future of medical imaging?

The Power of PET/MRI: Why It’s Superior
1. Unmatched Soft-Tissue Contrast with Functional Insights
While PET/CT combines metabolic imaging with anatomical detail, it relies on X-rays, which offer limited soft-tissue contrast. MRI, on the other hand, provides exquisite anatomical detail without ionizing radiation, making it ideal for imaging the brain, liver, pelvis, and musculoskeletal system.

By integrating PET’s metabolic data (e.g., glucose uptake via FDG-PET) with MRI’s high-resolution structural imaging, clinicians get a comprehensive view of both function and form—critical for detecting tumors, neurological disorders, and inflammatory diseases.

2. Reduced Radiation Exposure
One major advantage of PET/MRI over PET/CT is significantly lower radiation exposure. CT scans contribute a substantial dose, whereas MRI uses no ionizing radiation. This makes PET/MRI especially valuable for:
• Paediatric patients
• Longitudinal studies (e.g., monitoring cancer treatment)
• Conditions requiring repeated scans (e.g., neurodegenerative diseases)

3. Superior Neurological and Oncological Imaging
Neurology Applications:
• Alzheimer’s & Parkinson’s Disease: PET/MRI allows simultaneous assessment of amyloid plaques (PET) and brain atrophy (MRI).
• Epilepsy: Helps localize epileptogenic zones with both metabolic (PET) and structural (MRI) precision.
• Brain Tumors: Enhances differentiation between tumor recurrence and radiation necrosis.

Oncology Applications:
• Prostate Cancer: PET/MRI with PSMA (Prostate-Specific Membrane Antigen) tracers improves detection of small metastases.
• Breast & Liver Cancer: MRI’s superior soft-tissue contrast, combined with PET’s metabolic data, improves tumor characterization.
• Lymphoma & Pediatric Tumors: Reduces radiation burden while improving diagnostic accuracy.

4. Emerging Role in Cardiology
PET/MRI is gaining traction in cardiac imaging, offering:

• Viability assessment (MRI’s late gadolinium enhancement + PET’s metabolic data).
• Early detection of inflammation in myocarditis or sarcoidosis.
• Improved evaluation of atherosclerotic plaques.
Advancements in AI-based image reconstruction, faster MRI sequences, and novel PET tracers are interesting developments.

The Future of Hybrid Imaging
PET/MRI represents the next evolution in diagnostic imaging, offering unparalleled insights into disease processes while minimizing patient risk. As technology becomes more accessible and AI-driven enhancements reduce scan times, PET/MRI is poised to become the gold standard—particularly in oncology, neurology, and precision medicine.

Leadership and Expertise

Dr. Murali R. Nadig, a prominent figure in nuclear medicine and PETCT, serves as the Medical Director of NewMed Diagnostics in Bangalore. With a medical degree from Mysore and post-graduation from AIIMS, Delhi, Dr. Nadig brings extensive expertise to the center. NewMed Diagnostics is notable for being the first and only nuclear medicine, PETCT, and radio nuclear facility in the state, leading the field for the past four years.

The combination of advanced technology, skilled technicians, and direct involvement of doctors at NewMed Diagnostics Center underscores its commitment to providing top-tier diagnostic services, ensuring precise disease detection and effective treatment.

For more information, please contact:
NewMedd Diagnostics
Bengaluru
No. 110, KH Road (Double Road), Land Mark: Next to Suzuki Show Room, Sudhama Nagara, Bengaluru – 560027  Ph: 080-2222 4050 / 94812 12244
Mysuru
No 59, 3rd main, Behind Akashavani, Yadavagiri, Mysuru – 20
Ph 70268 22682 / 70267 22672

The post Positron Emission Tomography is Becoming the Gold Standard appeared first on Health Vision.

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide. It occurs when the coronary arteries that supply oxygen-rich blood to the heart become narrowed or blocked due to plaque build-up. Early and accurate detection of CAD is crucial for effective management and prevention of severe complications such as heart attacks. One of the most reliable diagnostic tools for CAD is Myocardial Perfusion Imaging (MPI), a type of nuclear cardiology test that assesses blood flow to the heart muscle.

What is Myocardial Perfusion Imaging?
Myocardial Perfusion Imaging (MPI) is a non-invasive imaging technique that evaluates the blood supply to the heart muscle both at rest and under stress. It uses a small amount of radioactive tracer, such as technetium-99m or thallium-201, which is injected into the bloodstream. A gamma camera detects the radiation emitted by the tracer, producing images of the heart that help identify areas with inadequate blood flow.

How MPI Detects Coronary Artery Disease
MPI is particularly effective in diagnosing CAD because it can reveal areas of the heart that receive reduced blood supply due to narrowed or blocked coronary arteries. The test is performed in two phases:
• Resting Phase – The patient receives the tracer injection while at rest, and images are taken to assess baseline blood flow to the heart.
• Stress Phase – The patient undergoes physical exercise on a treadmill or receives a pharmacologic stress agent (such as adenosine or dobutamine) to simulate the effects of exercise. The tracer is injected again, and additional images are captured.
By comparing the rest and stress images, doctors can determine if there are any areas of reduced blood flow, which is indicative of coronary artery disease.

Key Benefits of MPI in CAD Detection
• Early Diagnosis – MPI can detect CAD before symptoms such as chest pain (angina) appear.
• Assessing Severity – The test helps determine the extent and severity of coronary artery blockages.
• Guiding Treatment Decisions – MPI results help doctors decide whether a patient requires lifestyle modifications, medications, angioplasty, or coronary bypass surgery.
• Evaluating Treatment Effectiveness – After treatment, MPI can assess whether blood flow has improved.
• Predicting Future Cardiac Events – MPI provides valuable prognostic information on a patient’s risk of heart attack or other cardiac events.
• Non-Invasive – Unlike coronary angiography, MPI does not require inserting a catheter into the heart.
• High Sensitivity and Specificity – It provides accurate detection of CAD and assessment of blood flow abnormalities.

How MPI Assesses Blood Flow to the Heart
MPI is instrumental in assessing myocardial perfusion in several key ways:
• Detecting Coronary Artery Disease (CAD) – MPI helps identify narrowed or blocked coronary arteries by revealing areas of the heart that receive insufficient blood supply during stress.
• Evaluating the Severity of Ischemia – The test differentiates between mild and severe ischemia, helping physicians determine the urgency and type of intervention needed.
• Assessing Myocardial Viability – MPI can detect whether heart tissue is still viable and capable of recovery following a heart attack or if it has sustained irreversible damage.
• Monitoring Treatment Effectiveness – Physicians use MPI to assess the success of treatments such as medication, angioplasty, or coronary artery bypass surgery.
• Predicting Future Cardiac Events – The test provides valuable prognostic information, helping to estimate a patient’s risk of future heart attacks or cardiac complications.

When Should You Get a Myocardial Perfusion Scan?

• Symptoms Suggestive of Coronary Artery Disease (CAD): If you experience symptoms such as chest pain (angina), shortness of breath, fatigue, or unexplained dizziness, your doctor may suggest an MPS to determine whether your heart is receiving adequate blood supply.
• Abnormal Results from Other Tests: If an electrocardiogram (ECG), echocardiogram, or stress test shows abnormalities suggesting insufficient blood flow to the heart, an MPS can provide more detailed information about which areas of the heart are affected.
• Evaluating the Effectiveness of Previous Treatments: Patients who have undergone treatments such as coronary artery bypass grafting (CABG), angioplasty, or stent placement may need an MPS to assess the success of these procedures and ensure adequate blood flow is maintained.
• Determining the Severity of Coronary Blockages: If coronary artery disease has already been diagnosed, an MPS can help determine how severe the blockages are and whether further interventions, such as surgery or medication adjustments, are necessary.
• Pre-Surgical Evaluation for Non-Cardiac Surgery: For patients with risk factors for heart disease, an MPS may be required before undergoing major surgeries (e.g., orthopedic or abdominal surgeries) to evaluate cardiac function and ensure the heart can withstand the stress of the procedure.
• Assessing Heart Function in Patients with Previous Heart Attacks: If you have had a heart attack, an MPS can evaluate how well the heart muscle is functioning and identify any areas that may have been permanently damaged.
• Monitoring High-Risk Individuals: Individuals with multiple risk factors for heart disease—such as diabetes, hypertension, high cholesterol, smoking, obesity, or a strong family history of CAD—may undergo an MPS to detect potential heart problems early, even if they are asymptomatic.

Myocardial Perfusion Imaging is a highly effective tool for detecting coronary artery disease. By assessing blood flow to the heart under both rest and stress conditions, MPI helps identify blockages that could lead to serious heart complications. Its ability to guide treatment decisions and predict future cardiac events makes it a crucial component of modern cardiology. If you are at risk for CAD, consult doctor to see if MPI is right for you.

Leadership and Expertise

Dr. Murali R. Nadig, a prominent figure in nuclear medicine and PETCT, serves as the Medical Director of NewMed Diagnostics in Bangalore. With a medical degree from Mysore and post-graduation from AIIMS, Delhi, Dr. Nadig brings extensive expertise to the center. NewMed Diagnostics is notable for being the first and only nuclear medicine, PETCT, and radio nuclear facility in the state, leading the field for the past four years.

The combination of advanced technology, skilled technicians, and direct involvement of doctors at NewMed Diagnostics Center underscores its commitment to providing top-tier diagnostic services, ensuring precise disease detection and effective treatment.

For more information, please contact:
NewMedd Diagnostics
Bengaluru
No. 110, KH Road (Double Road), Land Mark: Next to Suzuki Show Room, Sudhama Nagara, Bengaluru – 560027  Ph: 080-2222 4050 / 94812 12244
Mysuru
No 59, 3rd main, Behind Akashavani, Yadavagiri, Mysuru – 20
Ph 70268 22682 / 70267 22672

The post How Myocardial Perfusion Imaging Helps Detect CAD appeared first on Health Vision.

Ahmedabad: Stavya Spine Hospital, a renowned leader in exclusive spine care for over two decades, has introduced the Open Standing Weight Bearing MRI(Manufactured by Esaote SpA Italy) to its suite of advanced diagnostic tools. This innovative technology, designed specifically to meet the unique demands of spine diagnostics, enables imaging in standing, sitting and supine positions, offering new dimensions in evaluating spine conditions. The addition of this tool underscores Stavya’s commitment to ethical care, transparency, and advancing patient outcomes.

Transforming Diagnostics with Open Standing MRI
Unlike conventional MRIs, which require patients to lie flat for higher-resolution imaging, the Open Standing Esaote’s MRI allows for weight-bearing assessments of the spine. This machine is particularly suited to dynamic evaluations of conditions such as scoliosis, degenerative disc disease, and spinal instability. For patients with claustrophobia or anxiety about traditional MRI machines, the Open Standing MRI provides a more comfortable and open environment. Additionally, this technology can also be used to image the knee and hip in weight-bearing positions, offering valuable insights into joint health.

Dr. Mirant Dave, Spine Surgeon at Stavya, explained, “Our diagnostic philosophy is rooted in understanding how the spine functions under real-life conditions. The Open Standing Esaote’s MRI helps us evaluate the behavior of the spine under load, which is invaluable when determining whether a condition requires surgical intervention or can be managed conservatively. This is another step in our mission to deliver ethical, evidence-based care.” The Open Standing MRI is an essential tool for conditions where dynamic, functional imaging is critical.

Advanced Spine Care at Stavya
Stavya Spine Hospital has set itself apart as a center of excellence for spine care, combining cutting-edge technology, expert medical professionals, and a patient-first philosophy. As the only hospital in India exclusively dedicated to spine care, Stavya offers a comprehensive range of advanced treatments and diagnostics:
• Robotics in Spine Surgery: Revolutionizing complex procedures with enhanced precision and minimal risk.
• Endoscopic Spine Surgery: Delivering minimally invasive solutions for faster recovery and reduced discomfort.
• German Advanced Physiotherapy: Employing structured, evidence-based rehabilitation techniques for long-term recovery.
These technologies and techniques have been meticulously integrated into Stavya’s framework to provide a holistic approach to spine care. Every patient’s journey—from diagnosis to treatment and rehabilitation—is tailored to their specific needs, ensuring optimal outcomes and long-term spine health.

Dr. Bharat Dave, Director and Spine Surgeon, remarked, “At Stavya, we have always prioritized integrating the best of technology, talent, and treatment methods to provide our patients with comprehensive spine care. The Open Standing MRI complements this approach, helping us better understand and treat conditions that require dynamic imaging.”

The Team of Experts at Stavya
Stavya Spine Hospital prides itself on its team of highly skilled spine surgeons and physiotherapists who are dedicated to providing the best care. The surgical team includes:
• Dr. Bharat Dave
• Dr. Mirant Dave
• Dr. Ajay Krishnan
• Dr. Hitesh Modi
• Dr. Shivanand Mayi
• Dr. Raviranjan Rai
• Dr. Mukesh Patel
• Dr. Devanand Degulmadi

Together, this team brings decades of experience and expertise in managing complex spine conditions through advanced surgical techniques and ethical decision-making. The team’s collaborative approach ensures every patient receives the most effective care, whether surgical or conservative.

Stavya also boasts a world-class physiotherapy team, led by Dr. Akruti Dave, that works in close coordination with the surgeons to create comprehensive rehabilitation plans. Their focus is on ensuring patients regain optimal mobility and strength, whether recovering from surgery or managing their condition through conservative means.

Physiotherapy and Spine Health Checkups
Physiotherapy is a cornerstone of spine care, and Stavya emphasizes its role in both surgical and non-surgical treatment plans. Tools like the Open Standing MRI are invaluable for understanding a patient’s functional limitations and tailoring rehabilitation programs accordingly.

Dr. Akruti Dave, Head of Physiotherapy, shared, “Physiotherapy plays a vital role in improving patient outcomes. The Open Standing MRI helps us assess the mechanical and functional aspects of the spine more effectively, which is essential in designing personalized recovery plans. It also enhances our ability to help patients who are pursuing conservative care options.”

In addition to rehabilitation, Stavya has introduced Spine Health Checkups, a comprehensive program aimed at early detection and prevention of spine-related issues. The Open Standing MRI plays a central role in these checkups by offering dynamic imaging that uncovers subtle abnormalities and helps guide proactive treatment.
Dr. Akruti Dave added, “Spine Health Checkups are critical for detecting problems early, especially in individuals with sedentary lifestyles, poor posture, or chronic back pain. The Open Standing MRI allows us to offer patients a detailed understanding of their spine health, enabling timely interventions that can prevent further complications.”

Two Decades of Trust and Global Impact
Stavya Spine Hospital has built a legacy of trust over 20 years, treating thousands of patients from across India and the world. Patients turn to Stavya not only for its advanced technology but also for the hospital’s unwavering commitment to ethical, patient-first care.
In addition to its clinical impact, Stavya has been instrumental in training over 100 spine surgeons, many of whom now practice internationally. This focus on education and mentorship has helped Stavya contribute to the global advancement of spine care, ensuring its expertise reaches far beyond the hospital’s walls.

A Vision for the Future: Asia’s Largest Exclusive Spine Hospital
Looking to the future, Stavya is preparing to launch a new Center of Excellence in 2025, which will be the largest exclusive spine hospital in Asia. This landmark facility will expand Stavya’s capabilities, featuring advanced diagnostic and treatment technologies, increased capacity for patient care, and dedicated spaces for research and education. This project underscores Stavya’s ambition to remain at the forefront of spine care globally.
Mrs. Amita Dave, Managing Director, stated, “As we prepare for this new chapter, our focus remains on maintaining the trust of our patients. The Open Standing MRI is more than just a new diagnostic tool—it reflects our values of transparency, ethics, and a commitment to providing the most appropriate care for each individual.”

The Value of Transparency in Diagnostics
At Stavya, transparency is central to its care philosophy. The introduction of the Open Standing MRI is no exception. By openly sharing the specifications and purpose of this tool, Stavya ensures patients understand its role in their diagnostic journey.

Dr. Preety Krishnan, Radiologist, explained, “The Open Standing MRI is an important tool for specific spine conditions that require imaging in natural, weight-bearing positions. It’s ability to provide functional insights into the spine’s behavior is invaluable for certain diagnoses. This transparency helps patients feel confident and informed about their care.”

The post Stavya Spine Hospital Introduces Advanced Spine Diagnostics appeared first on Health Vision.

The thyroid gland plays a crucial role in regulating metabolism, energy levels, and overall bodily functions. However, thyroid disorders are increasingly common, affecting millions worldwide. Nuclear medicine has become a vital tool in both the diagnosis and treatment of thyroid conditions, particularly for conditions like hyperthyroidism, hypothyroidism, thyroid cancer, and nodules.

The Role of the Thyroid Gland
The thyroid is a small, butterfly-shaped gland located in the neck. It produces hormones—mainly triiodothyronine (T3) and thyroxine (T4)—that regulate various bodily functions, including heart rate, temperature, and metabolic processes. When the thyroid’s function is compromised, it can lead to either an overactive (hyperthyroidism) or underactive (hypothyroidism) state, along with other potential complications.

Diagnosis of Thyroid Disorders Using Nuclear Medicine
In nuclear medicine, thyroid imaging typically uses small amounts of radioactive substances to diagnose and assess thyroid health. The two primary imaging techniques used are thyroid scans and uptake tests.

Thyroid Scans
A thyroid scan uses a small dose of a radioactive tracer, which is absorbed by the thyroid gland. A special camera, known as a gamma camera, captures images of the thyroid based on the radioactive material’s distribution. This scan can reveal:
• Nodules: Differentiates between benign and potentially malignant thyroid nodules.
• Size and Shape: Identifies structural abnormalities and helps detect enlarged or abnormally shaped thyroids.
• Hot and Cold Spots: “Hot” spots indicate areas of higher activity, often linked to hyperactive nodules, while “cold” spots suggest non-functioning or potentially malignant nodules.

Thyroid Uptake Test
In a thyroid uptake test, a radioactive iodine pill or liquid is ingested. The thyroid naturally absorbs iodine, so tracking the absorbed amount over a set period provides insights into thyroid activity levels. High iodine uptake is common in hyperthyroidism, while low uptake is indicative of hypothyroidism or other thyroid dysfunctions. This test is particularly effective for diagnosing conditions such as Graves’ disease or toxic multinodular goiter.

Treatment of Thyroid Using Nuclear Medicine
Beyond diagnosis, nuclear medicine offers innovative treatments for thyroid disorders, especially through radioactive iodine (RAI) therapy.
Radioactive Iodine Therapy (RAI)
Radioactive iodine therapy is commonly used to treat hyperthyroidism and certain types of thyroid cancer. Administered in pill or liquid form, radioactive iodine-131 is selectively taken up by thyroid cells, delivering targeted radiation that destroys overactive or malignant cells while minimizing harm to surrounding tissues. Key applications include:
• Hyperthyroidism: RAI effectively reduces thyroid hormone production by shrinking the gland and is often used for conditions like Graves’ disease.
• Thyroid Cancer: After surgical removal of the thyroid, RAI is sometimes administered to eliminate residual cancerous cells and prevent recurrence.
RAI therapy’s effectiveness largely depends on the dose, patient’s condition, and overall health. Most patients require only a single dose, but follow-up treatments are occasionally needed. Side effects are typically mild, though some patients may experience temporary dry mouth, neck tenderness, or fatigue.

Benefits of RAI Therapy
• Minimally Invasive: RAI therapy is non-surgical and relatively painless, allowing patients to return to daily activities soon after treatment.
• High Success Rate: Studies show high success rates in achieving remission for hyperthyroidism and certain thyroid cancers.
• Targeted Treatment: Since the thyroid naturally absorbs iodine, the radioactive iodine selectively targets thyroid tissue, minimizing radiation exposure to the rest of the body.

Safety and Risks of Nuclear Medicine in Thyroid Health
While nuclear medicine procedures for thyroid health are generally safe, they are not without some risks. However, the doses of radioactive substances used in diagnosis and treatment are carefully controlled to minimize potential adverse effects. Some considerations include:
• Exposure to Radiation: Though radiation exposure is minimal, patients undergoing RAI therapy are advised to take temporary precautions to limit radiation exposure to others.
• Long-Term Monitoring: Patients treated for thyroid cancer or with high doses of RAI may require follow-up care to monitor for potential long-term effects.
The benefits of early and accurate diagnosis, combined with the targeted effectiveness of nuclear treatments, often outweigh these risks, making nuclear medicine an essential approach to managing thyroid health.

Future Advances in Nuclear Medicine for Thyroid Health
With ongoing advancements in nuclear medicine technology, new techniques and tracers are being developed to improve the accuracy of thyroid diagnosis and the effectiveness of treatments. Molecular imaging advancements, for instance, hold the potential to detect thyroid issues at even earlier stages, helping to prevent disease progression.

Additionally, new therapies and isotopes under investigation aim to reduce side effects while enhancing therapeutic efficacy, promising an even brighter future for nuclear medicine in managing thyroid health.

From early detection of nodules to life-saving treatments for thyroid cancer, nuclear medicine continues to make strides in supporting thyroid health. As technology evolves, these techniques are only expected to become safer and more effective, making nuclear medicine a cornerstone in the field of thyroid care.

Dr. Murali R. Nadig
Dr. Murali R. Nadig, a leading name in Nuclear Medicine – PET/CT, is the Medical Director of NewMedd Diagnostics in Bangalore and Chief Advisor for Nuclear Medicine – PET/CT. He holds a medical degree from Mysore and a postgraduate degree from the prestigious AIIMS, specializing in Nuclear Medicine, Nuclear Cardiology, PET/CT, Hyperthyroidism, Thyroid Cancer, and Radio Nuclear Therapies. He founded Karnataka’s first Nuclear Medicine – PET/CT Diagnostic Center and has dedicated his time to advancing nuclear medicine and PET/CT diagnostics.

For more information, please contact:
NewMedd Diagnostics
Bengaluru
No. 110, KH Road (Double Road), Land Mark: Next to Suzuki Show Room, Sudhama Nagara, Bengaluru – 560027  Ph: 080-2222 4050 / 94812 12244
Mysuru
No 59, 3rd main, Behind Akashavani, Yadavagiri, Mysuru – 20
Ph 70268 22682 / 70267 22672

The post Nuclear Medicine in Thyroid Disorders – Diagnosis and Treatment appeared first on Health Vision.

AI is transforming the healthcare sector, and one of the arenas is drug discovery, which has proven to be very beneficial. Traditional methods of discovering a new drug for an illness depend on trial and error, which is laborious and expensive, and the result could be either a new drug that is ineffective or has severe side effects. This is where AI enters to create swifter and more effective therapies over time that are changing the drug discovery landscape. It helps to streamline this whole process in a fast and precise way by using automation for the completion of tasks, analyzing large quantities of data, or suggesting novel approaches. It accelerates the path from bench to bedside, from target identification to clinical studies.

One of the biggest challenges in drug discovery is identifying promising compounds. Using artificial intelligence algorithms, it can identify hidden patterns and connections, which may lead to new drug targets or suggest alternative combinations of existing medicines. In order to predict which compounds will be effective, machine learning algorithms can analyze vast amounts of data from past research, medical studies, and patients’ records. This will allow scientists to focus their efforts on the most promising drugs, saving time and resources in this process.

In addition, artificial intelligence is changing the way drugs are designed. It analyzes the structure and behavior of thousands of molecules at the same time, suggesting new configurations that could enhance potency and selectivity and reduce side effects. This allows for the rapid development of more targeted and personalized therapies. Furthermore, machine learning models are capable of analyzing complex biological systems and providing new ways to interact with them.

The potential benefits of AI in accelerating drug discovery and improving patient outcomes are undeniable. Companies are bringing drugs to market faster and at a lower cost, giving patients access to innovative treatments sooner. As AI technology progresses, we anticipate further remarkable discoveries in the future. Along with its benefits, AI also encounters some challenges. It is crucial to tackle ethical issues, like the possibility of AI algorithms being biased and the necessity of being transparent. Other data difficulties include growth, diversity and scale. Moreover, it is essential to use AI tools responsibly and guarantee that they do not jeopardize patient safety.

AI has the potential to read different stages of drug discovery effectively which includes drug design, chemical synthesis, screening of a drug, polypharmacology and repurposing. Using the advanced ability of AI to process huge amounts of data, we can solve some of the hardest health problems faced today and bring optimism to many people. Leading companies such as Peptris, Acubiosy, NATCO Pharma, DPHS India, Sanopeutics, Prescience Insilico, and Sai Life Sciences are some of the well-known firms in India that take part in the process of finding new drugs.

Peptris is focused on leveraging AI for drug research, with a strong emphasis on rare diseases, cancer, and inflammation, while Acubiosys focuses on creating natural, cost-effective medications for severe illnesses, aiming to mitigate the adverse effects of synthetic drugs.

NATCO Pharma is a company that specializes in creating new drugs for diseases that have no cure by using advanced methods of research and development, while another company, DPHS India, known for its superior pharmaceutical products, covers a wide range of medical needs, and for its expertise in conducting clinical trials and advancing medical innovation. Prescience Insilico, a cutting-edge technology firm, uses AI and machine learning to expedite the process of discovering and developing new drugs and materials. Meanwhile, Sai Life Sciences is a reliable partner for small-molecule drug discovery, assisting biotechnology and pharmaceutical companies in India to speed up their drug development process from finding a potential drug to launching it. All these companies offer innovative solutions and instill hope in the healthcare industry.

The influence of AI in the pharmaceutical industry extends beyond India with groundbreaking advancements in drug discovery and development happening worldwide. For instance, Atomwise utilized its deep learning AI model to screen potential drug candidates for Ebola. Similarly, Turbine.AI developed an AI system capable of identifying optimal drug combinations to target specific tumor types and biomarkers. Additionally, Insilico Medicine has leveraged its AI platform to discover and advance promising drug candidates for treating idiopathic pulmonary fibrosis.

Also read: What is an adverse drug reaction (ADR)?

The recent growth in India’s drug discovery and pharmaceutical sectors is remarkable, as we witness the expansion of drug discovery development globally. With a diverse range of pharmaceutical companies excelling in high-quality, proprietary drug discovery and providing innovative solutions, India is making significant contributions to the drug development pipeline worldwide and opening opportunities for various business opportunities, including logistics, knowledge exchange, and intellectual property in the healthcare industry.

Dr. Arpita Goyal
Yale Scholar

The post Artificial Intelligence in Drug Discovery – Transforming Healthcare Sector appeared first on Health Vision.

With a strong commitment to patient-centric care, advanced medical technologies, and a team of highly skilled medical professionals, the hospital has earned a stellar reputation for providing top-notch services in kidney stone diagnosis, treatment, and prevention.

State-of-the-Art Facilities:

The hospital is equipped with state-of-the-art facilities and cutting-edge medical equipment, ensuring accurate diagnosis and effective treatment of kidney stones. Advanced imaging technologies, such as high-resolution ultrasound, CT scans, and MRI, aid in precise stone localization and characterization. These facilities play a crucial role in tailoring personalized treatment plans for each patient.

Expert Medical Team:

At Hitech Kidney Stone Hospital, the medical team is composed of board-certified urologists, nephrologists, radiologists, and other specialists who possess extensive experience in managing kidney stone cases. Their deep expertise ensures that patients receive the most appropriate and effective care. The hospital’s commitment to continuous medical education and research keeps the team at the forefront of the latest advancements in kidney stone treatment.

Comprehensive Treatment Options:

The hospital offers a wide range of treatment options, including:

• Minimally Invasive Procedures: Hitech Kidney Stone Hospital specializes in minimally invasive techniques such as Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy (PCNL). These procedures minimize patient discomfort, reduce recovery time, and offer excellent stone clearance rates.
• Laser Lithotripsy: The hospital is a pioneer in employing laser technology for precise and effective stone fragmentation. This technique ensures minimal damage to surrounding tissues, enhancing patient outcomes and reducing complications.
• Medical Management and Prevention: Beyond treatment, the hospital places significant emphasis on patient education and preventive care. Through personalized dietary and lifestyle counseling, patients are empowered to make informed choices that reduce the risk of recurrent kidney stones.

Patient-Centric Approach:

Hitech Kidney Stone Hospital is renowned for its patient-centric approach. From the moment a patient enters the hospital, they are greeted with compassion and understanding. The hospital’s staff is dedicated to providing a supportive environment, addressing patient concerns, and ensuring a comfortable experience throughout the treatment journey.

Holistic Care:

Recognizing that kidney stone treatment involves more than just medical interventions, Hitech Kidney Stone Hospital offers holistic care that addresses the physical, emotional, and psychological aspects of the patient’s well-being. This approach fosters a sense of trust and partnership between patients and healthcare providers, leading to better treatment outcomes.

Community Outreach and Education:

The hospital extends its impact beyond its walls by engaging in community outreach programs and educational initiatives. Regular workshops, seminars, and awareness campaigns are organized to educate the public about kidney stone prevention, symptoms, and treatment options. This proactive approach underscores the hospital’s commitment to promoting kidney health and well-being on a larger scale.

Conclusion:

Hitech Kidney Stone Hospital stands as a shining example of excellence in kidney stone care. It has different centers at – Kumarapark East, Bengaluru; Jayanagar, Bengaluru; and Mysuru.  With its state-of-the-art facilities, expert medical team, patient-centric approach, and comprehensive treatment options, the hospital has earned its reputation as a trusted destination for individuals seeking effective and compassionate kidney stone care. Through its dedication to quality services and continuous innovation, Hitech Kidney Stone Hospital continues to make remarkable strides in improving the lives of those affected by kidney stones.

The post Hitech Kidney Stone Hospital: Pioneering Excellence in Kidney Stone Care appeared first on Health Vision.

It has been felt that 10% of the population suffer from kidney stones, which produces severe pain to the patients which eventually leads to the loss of kidney. Kidney stones, medically known as nephrolithiasis, are a common ailment that affects a significant portion of the population. These small, hard deposits can form in the kidneys and cause excruciating pain, often necessitating medical intervention.

Kidney stones are solid crystalline structures that form from substances found in urine. These substances can include calcium, oxalate, uric acid, and cysteine. The crystals combine to form stones of varying sizes, which can become trapped in the urinary tract, leading to severe pain, urinary tract infections, and potential kidney damage.

There is increase in kidney stones due to dietary and lifestyle factors. It is estimated that approximately 10% of the global population experiences kidney stones at some point in their lives, highlighting the prevalence and importance of addressing this issue. Furthermore, if left untreated, kidney stones can obstruct the flow of urine and cause irreversible damage to the kidneys, ultimately leading to kidney failure.

Traditional Treatment Methods:

Historically, treating kidney stones often involved invasive procedures such as forced diuresis, percutaneous nephrolithotomy (PCNL), and open surgery. Forced diuresis aims to increase urine production to flush out the stones, but it can be uncomfortable for the patient and may not always yield effective results. PCNL involves surgically removing the stones through a small incision in the back, and open surgery is a more extensive procedure that requires larger incisions.

Both methods typically require hospitalization and specialized care by urology specialists, leading to prolonged recovery times and potential complications. However, recent advancements in medical technology have led to innovative approaches that provide more efficient and patient-friendly alternatives.

Innovative Approach: Lithotripsy

A pioneering approach to kidney stone treatment involves state-of-the-art lithotripter equipment. This cutting-edge technology offers a non-invasive and patient-friendly method for breaking down kidney stones. The procedure, known as extracorporeal shock wave lithotripsy (ESWL), uses focused shock waves to target and break down the stones into smaller fragments that can be passed more easily through the urinary tract. ESWL eliminates the need for surgical incisions, reduces hospitalization time, and minimizes discomfort for the patient.

Collaborative Care: Bridging the Gap Between Patients and Urologists

The comprehensive approach to kidney stone treatment involves a collaborative effort between patients and qualified urologists. Upon diagnosis, patients are provided with consultations from experienced urologists who assess the severity of the condition and recommend an appropriate treatment plan. If ESWL is deemed suitable, patients are guided through the procedure, ensuring they receive personalized care and support at every step of the process.

Conclusion:

Kidney stones present a significant health challenge that affects a substantial population. The debilitating pain and potential long-term consequences underscore the importance of timely and effective treatment. Traditional approaches involving forced diuresis, PCNL, and open surgery have been the norm, but advancements in medical technology have introduced innovative alternatives.

State-of-the-art lithotripter equipment and extracorporeal shock wave lithotripsy provide patients with a less invasive and more convenient option for kidney stone removal. Coupled with expert consultation and collaborative care, these innovative approaches are transforming the landscape of kidney stone treatment, offering patients a brighter and less painful path to recovery.

Hitech Kidney Stone Hospital, Bengaluru offers quality services, cost effective treatment and good patient care. Patients can visit hospital at its different centers at – Kumarapark East, Bengaluru; Jayanagar, Bengaluru; and Mysuru.

The post Kidney Stones: Lithotripsy an Innovative Treatment Approach appeared first on Health Vision.

 ZEISS Medical Technology, which remains committed to driving progress, efficiency, and access to healthcare technology, supporting doctors to improve their patients’ quality of life, has seen a significant rise in the adoption of SMILE (Small Incision Lenticule Extraction) technology in India. As a groundbreaking and minimally invasive vision correction procedure, ZEISS SMILE (Small Incision Lenticule Extraction) procedures have experienced fast growth in the Indian market, revolutionizing the way people address refractive errors and achieve clearer vision.

ZEISS SMILE represents a paradigm shift in laser eye surgery, providing patients with a reliable and precise solution to common vision problems such as myopia (nearsightedness) and astigmatism. Since its introduction to the Indian market in 2008, ZEISS SMILE has garnered widespread attention and acceptance from both eye care professionals and patients due to its unique advantages and transformative benefits. In the past 10 years, 200,000+ eyes have been successfully treated by ZEISS SMILE procedures in India. Globally, ZEISS has facilitated 8 million + SMILE procedures.

Key features and benefits of ZEISS SMILE technology include:

• Minimally Invasive Procedure: ZEISS SMILE requires only a tiny incision, typically around 2mm, making it a minimally invasive and flapless laser eye surgery. This helps to reduce the risk of complications and contributes to a quicker recovery for patients.
• Enhanced Safety: The procedure involves the use of femtosecond laser technology, which allows for precise and gentle treatment. With its high level of safety, ZEISS SMILE has been widely recognized as a well-suited option for a broad range of patients across all professions and lifestyles, particularly for defense and military personnel, athletes of all levels, people in the fashion industry, university students and prospective brides to name a few. Faster Recovery: Patients can experience faster visual recovery with ZEISS SMILE compared to traditional LASIK procedures. Many individuals report improved vision almost immediately after the surgery.
• High Precision: ZEISS SMILE employs cutting-edge laser technology, enabling eye care professionals to achieve an exceptionally accurate and predictable outcome in vision correction.
• Reduced Dry Eye Incidence: As ZEISS SMILE does not require the creation of a corneal flap, it may lead to a reduced occurrence of dry eye symptoms, offering a more comfortable post-operative experience for patients.

“Lenticule Extraction with ZEISS SMILE has emerged as a game changer for individuals seeking a spectacle-free life. It is not just a procedure; it empowers individuals to see the world with newfound sharpness and freedom. I recommend this Lenticule Extraction procedure to eligible patients currently wearing minus-powered glasses, be it for sphere or cylinder correction, or astigmatism. In my point of view, the unparalleled precision offered by ZEISS SMILE is a hallmark of this cutting-edge refractive technology. With very accurate correction, patients experience clear vision. The procedure involves only a very small incision, leading to a smaller wound and allowing for an early recovery. This aspect is particularly noteworthy, as patients can quickly resume their daily activities with minimal downtime.

Moreover, Lenticule Extraction with ZEISS SMILE has been proven to provide long-term stability, and complications are remarkably infrequent, making it a safe and reliable option for vision correction. As an ophthalmologist, witnessing the life-changing results that ZEISS SMILE offers to patients is truly gratifying. I firmly believe that ZEISS SMILE represents the future of modern refractive technology. The shift towards lenticule-based procedures is inevitable. I foresee other refractive technologies across the globe adopting this revolutionary approach” said Dr Sonu Goel, Phaco Refractive Surgeon, Director, Anand Eye Hospital

“I believe, Lenticule Extraction with ZEISS SMILE is one of the paths to a sharp vision. With over a decade of outstanding experience, our Center proudly endorses ZEISS SMILE as a solution for laser refractive correction. Our patients consistently report great visual outcomes and long-term stability without unwanted after-effects such as residual dry eye. SMILE stands out as the preferred choice, empowering individuals to swiftly resume their regular lifestyle merely days after the procedure. I wholeheartedly recommend SMILE to every eligible individual seeking freedom from glasses.” said  Dr. Aadithreya Varman, Director, Uma Eye Clinic

“Within the realm of ophthalmology, the SMILE procedure stands as a remarkable testament to the blend of innovation and best patient outcome. I believe as surgeons our commitment extends beyond just correcting refractive errors; it is about creating a brighter world for each individual who entrusts us. Through surgical precision, SMILE is carving pathways to clearer sight and enhanced quality of life. I recommend SMILE to those who are eligible for Refractive Surgery, especially for athletes and sports enthusiasts as it avoids flap-related complications and ensures fast recovery. It is a minimally invasive, painless and flapless technique for the Myopic population as well as for individuals with milder forms of Astigmatism. SMILE has been delivering a good experience for me and my patients. I feel this technique is the future of Refractive Surgery.”  said Dr Ramya Sampath, Regional Head – Clinical Services, Dr. Agarwal Eye Clinic

As ZEISS SMILE continues to gain popularity, it represents a significant advancement in the field of vision correction. Its precision, safety, and quick recovery times make it a compelling choice for both eye care professionals and patients who are seeking a reliable and effective solution for their refractive errors. With its ongoing growth and adoption in India and around the world, ZEISS SMILE is reshaping the way people achieve a clearer vision and improving the quality of life for countless individuals.

ZEISS Medical Technology division is committed to working closely with Indian eye care professionals to expand access to ZEISS SMILE technology and ensure the best possible patient outcomes in the region.

By collaborating with leading eye care professionals, reputable clinics and eye centers, ZEISS aims to ensure that more individuals can benefit from this cutting-edge procedure for vision correction.

The post ZEISS SMILE: Pioneering Vision Correction Technology appeared first on Health Vision.